Is Medibank’s sale a dud deal for taxpayers?

Advertisement
ScreenHunter_5121 Nov. 24 12.54

By Leith van Onselen

Business Spectator’s Alan Kohler has penned an interesting rebuke of the Medibank privatisation today, arguing that it represents a dud deal for taxpayers:

…someone might have pointed out (but didn’t) that taxpayers are forgoing a dividend of $231m that grows each year, and could have borrowed that $5.7 billion for $185.4m in interest, fixed for 10 years.

The full text of this article is available to MacroBusiness subscribers

$1 for your first month, then:
Cancel at any time through our billing provider, Stripe
About the author
Leith van Onselen is Chief Economist at the MB Fund and MB Super. He is also a co-founder of MacroBusiness. Leith has previously worked at the Australian Treasury, Victorian Treasury and Goldman Sachs.